These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17913943)

  • 1. The theory of the sick breast lobe and the possible consequences.
    Tot T
    Int J Surg Pathol; 2007 Oct; 15(4):369-75. PubMed ID: 17913943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
    Dauplat MM; Penault-Llorca F
    Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stages on the way to breast cancer.
    Going JJ
    J Pathol; 2003 Jan; 199(1):1-3. PubMed ID: 12474219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DCIS, cytokeratins, and the theory of the sick lobe.
    Tot T
    Virchows Arch; 2005 Jul; 447(1):1-8. PubMed ID: 15926070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal carcinoma in situ in breast carcinogenesis.
    van Diest PJ
    J Pathol; 1999 Mar; 187(4):383-4. PubMed ID: 10398095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer.
    Rennstam K; Hedenfalk I
    Breast Cancer Res; 2006; 8(4):213. PubMed ID: 16895590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Benign and premalignant breast lesions--clinico-pathological correlation].
    Afek A; Shibi R; Kopolovitz G
    Harefuah; 1997 Nov; 133(9):375-8. PubMed ID: 9418343
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphogenesis of dysplasia and lobular cancer of the breast].
    Gol'bert ZV; Sorkin EE; Frank GA
    Vopr Onkol; 1978; 24(11):58-64. PubMed ID: 741701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mastopathy with atypia (mastopathy III) vs. minimal carcinoma in situ (MCIS)].
    Prechtel K
    Radiologe; 1996 Sep; 36(9):761-2. PubMed ID: 8999455
    [No Abstract]   [Full Text] [Related]  

  • 12. [Atypical ductal and lobular hyperplasia of the breast].
    Bricou A; Delpech Y; Barranger E
    Gynecol Obstet Fertil; 2009 Oct; 37(10):814-9. PubMed ID: 19766043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
    Xu S; Wei B; Zhang H; Qing M; Bu H
    Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative study of ductal breast cancer progression. A progression index (P.I.) for premalignant lesions and in situ carcinoma.
    Mariuzzi GM; Mariuzzi L; Mombello A; Santinelli A; Valli M; Rahal D; Thompson D; Bartels PH
    Pathol Res Pract; 1996 May; 192(5):428-36. PubMed ID: 8832747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
    Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
    Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.
    Wagner PL; Kitabayashi N; Chen YT; Shin SJ
    Am J Clin Pathol; 2009 Dec; 132(6):871-6. PubMed ID: 19926578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA content and cell number determination in microdissected samples of breast carcinoma in situ.
    Blumenstein R; Dias M; Russo IH; Tahin Q; Russo J
    Int J Oncol; 2002 Aug; 21(2):447-50. PubMed ID: 12118344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal carcinoma in situ: state of the science and roadmap to advance the field.
    Kuerer HM; Albarracin CT; Yang WT; Cardiff RD; Brewster AM; Symmans WF; Hylton NM; Middleton LP; Krishnamurthy S; Perkins GH; Babiera G; Edgerton ME; Czerniecki BJ; Arun BK; Hortobagyi GN
    J Clin Oncol; 2009 Jan; 27(2):279-88. PubMed ID: 19064970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
    Tot T
    Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.